SUSMED,Inc. (TYO:4263)

SUSMED,Inc. Revenue

In the fiscal year ending June 30, 2026, SUSMED,Inc. had annual revenue of 497.00M JPY with 7.58% growth. SUSMED,Inc. had revenue of 267.00M in the quarter ending June 30, 2026, with 506.82% growth. That makes SUSMED,Inc. the 41,334th largest company in the world by revenue and 3,833rd in Japan.

• Revenue: 497.00M
• Revenue Growth: +7.58%
• P/S Ratio: 11.81
• Revenue / Employee: 9.94M
• Employees: 50
• Market Cap: 5.87B

Revenue Chart

Chart

Chart

Revenue by Segment

• Digital Therapeutics Product 200.00M 58.4%
• Digital Therapeutics Platform 142.58M 41.6%

Fiscal year ended Jun 30, 2024 See the full SUSMED,Inc. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	497.00M	35.00M	7.58%
Jun 30, 2025	462.00M	120.00M	35.09%
Jun 30, 2024	342.00M	-188.00M	-35.47%
Jun 30, 2023	530.00M	214.00M	67.72%
Jun 30, 2022	316.00M	201.00M	174.78%

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error